StonvexLoading…
StonvexStonvexStonvexCore line items from PD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $492.55M | $367.76M | $243.22M | $119.81M |
Operating Income | $5.84M | $1.32M | $-6.76M | $-10.33M |
Net Income | $173.37M | $164.00M | $2.41M | $-7.16M |
EPS (Diluted) | $1.87 | $1.73 | $0.03 | $-0.07 |
Total Assets | $990.51M | $1.03B | $891.53M | $926.80M |
Total Liabilities | $719.85M | $688.45M | $693.85M | $763.81M |
Cash & Equivalents | $237.40M | $324.26M | $339.71M | $371.83M |
Free Cash Flow OCF − CapEx | $111.92M | $87.39M | $63.33M | $30.23M |
Shares Outstanding | 84.62M | 94.15M | 93.89M | 91.37M |